Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 739 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Dutch health minister considers compulsory license over drug prices. DIA Daily 2017:1. [Ref.ID 102148]
2. Cita con resumen
Hernández-Aguado I, Chilet-Rosell E. Pathways of undue influence in health policy-making: a main actor's perspective. J Epidemiol Community Health 2017:27 de octubre. [Ref.ID 102141]
4. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
5. Cita con resumen
Zaman MJ. Cost saving is nothing to be proud of. BMJ 2017;358:j3428. [Ref.ID 101978]
6. Cita con resumen
Anónimo. More doctors disclose payments from drug companies . BMJ 2017;358:30 de junio. [Ref.ID 101667]
7. Cita con resumen
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoen-baum M, Hutchins D, Brennan T, Loewen-stein G. Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA 2017;317:1785-95. [Ref.ID 101559]
8. Cita con resumen
10. Cita con resumen
Middleton J, McGrail S, Stringer K. Drug related deaths in England and Wales. BMJ 2016;355:i5259. [Ref.ID 100851]
11. Cita con resumen
Sheldon T. Saving antibiotics for when they are really needed: the Dutch example. BMJ 2016;354:i4192. [Ref.ID 100707]
12.Enlace a cita original Cita con resumen
Anónimo. Access to medicines—the status quo is no longer an option. Lancet 2016;388:1250. [Ref.ID 100699]
13. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
14. Cita con resumen
Crow D. Poorer countries need rapid access to generic drugs, UN says. Financial Times 2016:1. [Ref.ID 100663]
16. Cita con resumen
Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016;316:858-71. [Ref.ID 100589]
18. Cita con resumen
Johansen ME, Richardson C. Estimation of potential savings through therapeutic substitution. JAMA Intern Med 2016;176:769-75. [Ref.ID 100398]
19. Cita con resumen
Garattini S. The European Medicines Agency is still too close to industry. BMJ 2016;353:i2412. [Ref.ID 100360]
20. Cita con resumen
Alpern JD, Song J, Stauffer WM. Essential medicines in the United States - Why access is diminishing. N Engl J Med 2016;374:1904-7. [Ref.ID 100324]
Seleccionar todas
 
 1 a 20 de 739 siguiente >>